ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
Launched by ALBERT EINSTEIN COLLEGE OF MEDICINE · May 9, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Soon after birth, all babies born in the United States have a newborn screening (NBS) test to check for certain medical conditions. All babies are screened, even if they appear healthy, because most of these conditions have no obvious physical findings in a newborn and might otherwise be diagnosed only after the development of serious problems, such as brain damage, organ damage, or death. In fact, NBS has been an integral part of preventable health care for over five decades, ever since the discovery that phenylketonuria is an easily diagnosed, preventable cause of intellectual disability....
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All newborn infants born at a ScreenPlus pilot hospital
- • Infants who are less than four weeks old, regardless of sex, gestational age, or health status.
- Exclusion Criteria:
- • A newborn screening sample is unavailable
- • Infants who are more than four weeks old
About Albert Einstein College Of Medicine
Albert Einstein College of Medicine is a leading academic institution dedicated to advancing biomedical research and medical education. Situated in the Bronx, New York, it is renowned for its commitment to innovative research and training the next generation of physicians and scientists. The college actively engages in a wide range of clinical trials, focusing on translating scientific discoveries into effective therapies and improving patient care. With a collaborative approach that involves multidisciplinary teams, Albert Einstein College of Medicine aims to address significant health challenges and contribute to the global medical community through rigorous research and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Manhasset, New York, United States
New York, New York, United States
Stony Brook, New York, United States
New York, New York, United States
Bronx, New York, United States
New York, New York, United States
Brooklyn, New York, United States
Queens, New York, United States
Bronx, New York, United States
New York, New York, United States
Patients applied
Trial Officials
Melissa Wasserstein, MD
Principal Investigator
Albert Einstein College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials